Search research articles
Contact Us
Filters
Showing results (111-120 of 275) with videos related to
Page
of 28
Sort By:
Allergy
|
June 24, 2006
Predicting side-effects in venom immunotherapy by basophil activation?
B Eberlein-König, C Schmidt-Leidescher, H Behrendt, et al.
Chemotherapy
|
January 1, 1984
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G
H C Korting, H Behrendt, K H Roth, et al.
National Cancer Institute Monograph
|
April 1, 1981
Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation
P A Voûte, A Vos, J de Kraker, et al.
Allergy
|
October 18, 2008
Gender difference, sex hormones, and immediate type hypersensitivity reactions
W Chen, M Mempel, W Schober, et al.
Environmental Science and Pollution Research International
|
November 16, 2013
Uptake of terbuthylazine and its medium polar metabolites into maize plants
S Gayler, S Trapp, M Matthies, et al.
Cancer
|
June 1, 1987
Treatment of Hodgkin's disease in children with or without radiotherapy
H Behrendt, B N Van Bunningen, E F Van Leeuwen
Allergy
|
August 1, 1996
Atopic eczema and other manifestations of atopy: results of a study in East and West Germany
T Schäfer, D Vieluf, H Behrendt, et al.
The British Journal of Dermatology
|
December 9, 1997
Experiences with the severity scoring of atopic dermatitis in a population of German pre-school children
T Schäfer, D Dockery, U Krämer, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
Possible role of macrophages in allergic rhinitis
C Bachert, H Behrendt, K Nosbüsch, et al.
British Journal of Haematology
|
June 10, 2000
Persistent mediastinal mass is not indicative of recurrence after chemotherapy only in paediatric Hodgkin's disease
H Van Den Berg, L Verhulst, H Behrendt, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 275) with videos related to
Sort By:
Page
of 28
Allergy
|
June 24, 2006
Predicting side-effects in venom immunotherapy by basophil activation?
B Eberlein-König, C Schmidt-Leidescher, H Behrendt, et al.
Chemotherapy
|
January 1, 1984
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G
H C Korting, H Behrendt, K H Roth, et al.
National Cancer Institute Monograph
|
April 1, 1981
Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation
P A Voûte, A Vos, J de Kraker, et al.
Allergy
|
October 18, 2008
Gender difference, sex hormones, and immediate type hypersensitivity reactions
W Chen, M Mempel, W Schober, et al.
Environmental Science and Pollution Research International
|
November 16, 2013
Uptake of terbuthylazine and its medium polar metabolites into maize plants
S Gayler, S Trapp, M Matthies, et al.
Cancer
|
June 1, 1987
Treatment of Hodgkin's disease in children with or without radiotherapy
H Behrendt, B N Van Bunningen, E F Van Leeuwen
Allergy
|
August 1, 1996
Atopic eczema and other manifestations of atopy: results of a study in East and West Germany
T Schäfer, D Vieluf, H Behrendt, et al.
The British Journal of Dermatology
|
December 9, 1997
Experiences with the severity scoring of atopic dermatitis in a population of German pre-school children
T Schäfer, D Dockery, U Krämer, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
Possible role of macrophages in allergic rhinitis
C Bachert, H Behrendt, K Nosbüsch, et al.
British Journal of Haematology
|
June 10, 2000
Persistent mediastinal mass is not indicative of recurrence after chemotherapy only in paediatric Hodgkin's disease
H Van Den Berg, L Verhulst, H Behrendt, et al.
Page
of 28